Open AccessIs cytochrome modulation the new frontier for decreasing the risk of cataract?
Author(s) -
Jaykaran
Publication year - 2009
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.59931
Subject(s) - pioglitazone , cyp3a4 , medicine , endocrinology , urine , chemistry , enzyme inducer , troglitazone , cyp3a , urinary system , excretion , diabetes mellitus , cytochrome p450 , enzyme , peroxisome proliferator activated receptor , metabolism , type 2 diabetes , receptor , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom